http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102746337-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1cc134e139490e374ccf80c05d94857 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82a6e29c67f9b1c05b2f642af53ce3c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b1c1dd3f60d82675d39293ef2a859cb |
| publicationDate | 2014-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102746337-B |
| titleOfInvention | 2,4-pyrimidinediamine compound and preparation method thereof |
| abstract | The invention relates to the field of pharmaceutical chemistry synthesis, and specially relates to a 2,4-pyrimidinediamine compound, a preparation method and a application thereof. In-vitro experiments prove that the compound can significantly inhibit the activity of SYK kinase. Simultaneously, an investigation on collagen-induced rheumatoid arthritis rat model shows that the compound has relatively good anti-inflammatory action and can be used for preparing drugs for treating rheumatoid arthritis. |
| priorityDate | 2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.